Antiviral Drug Development: Innovations and Applications
Shaping the Future of Public Health: Innovate in Antiviral Drug Development
Skills you will gain:
Antiviral Drug Development: Innovations and Applications is an intensive program designed to introduce participants to the dynamic field of antiviral research and pharmaceutical development. This program will cover fundamental virology, the mechanisms of viral entry and replication, and the current landscape of antiviral therapies including small molecule drugs, vaccines, and novel therapeutic strategies such as RNA interference and CRISPR-based treatments.
Aim: This program aims to equip participants with cutting-edge knowledge and practical skills necessary for the development and application of antiviral drugs. It focuses on the latest research, innovation in drug design, and the application of these drugs in managing and treating viral infections effectively.
Program Objectives:
- Explore the diverse range of viruses and their impact on human health.
- Gain insights into the drug discovery process for antiviral therapies.
- Understand the mechanisms of action of different antiviral drugs.
- Analyze the challenges associated with antiviral drug resistance.
- Discuss the latest innovations in antiviral drug development, including gene editing and RNA interference
What you will learn?
Week 1: Virology and Drug Discovery Fundamentals
-
Viral replication cycles and molecular targets
-
Host-virus interactions and immune evasion mechanisms
-
Antiviral drug classifications and mechanisms of action
-
Historical milestones in antiviral therapeutics
Week 2: Drug Design Strategies and Screening Technologies
-
Rational drug design and structure-based approaches
-
High-throughput screening and compound libraries
-
In vitro antiviral assays and viral inhibition metrics
-
Computational modeling and AI-assisted drug prediction
Week 3: Therapeutic Innovation and Delivery Systems
-
Nucleoside analogues, protease inhibitors, and fusion blockers
-
Nanotechnology and targeted delivery platforms
-
Drug resistance and viral mutation management
-
Repurposing drugs for emerging viral infections
Week 4: Translational Research, Trials, and Regulatory Pathways
-
Clinical development pipeline and trial design
-
Regulatory compliance (FDA, EMA, CDSCO)
-
Emergency use authorization and pandemic preparedness
-
Future directions: mRNA antivirals, AI-driven formulation, global access
Intended For :
-
Students & Postgraduates in Virology, Pharmaceutical Sciences, Biotechnology, or Molecular Biology
-
PhD Scholars & Researchers involved in drug development, virology, or host-pathogen biology
-
Professionals in pharma R&D, biotech innovation, or regulatory affairs
-
Health Tech Entrepreneurs & Scientists exploring AI, nanotech, or bioinformatics in antiviral therapy
Career Supporting Skills